Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis

被引:1319
作者
Sartor, RB
机构
[1] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Div Gastroenterol & Hepatol, Multidisciplinary Inflammatory Bowel Dis Ctr, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Div Gastroenterol & Hepatol, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27599 USA
来源
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY | 2006年 / 3卷 / 07期
关键词
animal models; bacteria; Crohn's disease; pathogenesis; ulcerative colitis;
D O I
10.1038/ncpgasthep0528
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Crohn's disease and ulcerative colitis are idiopathic, chronic, relapsing, inflammatory conditions that are immunologically mediated. Although their exact etiologies remain uncertain, results from research in animal models, human genetics, basic science and clinical trials have provided important new insights into the pathogenesis of chronic, immune-mediated, intestinal inflammation. These studies indicate that Crohn's disease and ulcerative colitis are heterogeneous diseases characterized by various genetic abnormalities that lead to overly aggressive T-cell responses to a subset of commensal enteric bacteria. The onset and reactivation of disease are triggered by environmental factors that transiently break the mucosal barrier, stimulate immune responses or alter the balance between beneficial and pathogenic enteric bacteria. Different genetic abnormalities can lead to similar disease phenotypes; these genetic changes can be broadly characterized as cause in defects in mucosal barrier function, immunoregulation or bacterial clearance. These new insights will help develop better diagnostic approaches that identify clinically important subsets of patients for whom the natural history of disease and response to treatment are predictable.
引用
收藏
页码:390 / 407
页数:18
相关论文
共 139 条
  • [21] POSSIBLE ROLE OF MYCOBACTERIA IN INFLAMMATORY BOWEL-DISEASE .1. AN UNCLASSIFIED MYCOBACTERIUM SPECIES ISOLATED FROM PATIENTS WITH CROHNS-DISEASE
    CHIODINI, RJ
    VANKRUININGEN, HJ
    THAYER, WR
    MERKAL, RS
    COUTU, JA
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1984, 29 (12) : 1073 - 1079
  • [22] Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora
    Cong, YZ
    Weaver, CT
    Lazenby, A
    Elson, CO
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (11) : 6112 - 6119
  • [23] CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn's disease
    Connor, SJ
    Paraskevopoulos, N
    Newman, R
    Cuan, N
    Hampartzoumian, T
    Lloyd, AR
    Grimm, MC
    [J]. GUT, 2004, 53 (09) : 1287 - 1294
  • [24] Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice
    Cosnes, J
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (03) : 481 - 496
  • [25] High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease
    Darfeuille-Michaud, A
    Boudeau, J
    Bulois, P
    Neut, C
    Glasser, AL
    Barnich, N
    Bringer, MA
    Swidsinski, A
    Beaugerie, L
    Colombel, JF
    [J]. GASTROENTEROLOGY, 2004, 127 (02) : 412 - 421
  • [26] Adherent-invasive Escherichia coli:: a putative new E-coli pathotype associated with Crohn's disease
    Darfeuille-Michaud, A
    [J]. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2002, 292 (3-4) : 185 - 193
  • [27] Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment
    Dieleman, LA
    Goerres, MS
    Arends, A
    Sprengers, D
    Torrice, C
    Hoentjen, F
    Grenther, WB
    Sartor, RB
    [J]. GUT, 2003, 52 (03) : 370 - 376
  • [28] Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn's disease
    Doering, J
    Begue, B
    Lentze, MJ
    Rieux-Laucat, F
    Goulet, O
    Schmitz, J
    Cerf-Bensussan, N
    Ruemmele, FM
    [J]. GUT, 2004, 53 (11) : 1632 - 1638
  • [29] Impaired expression of peroxisome proliferator-activated receptor γ in ulcerative colitis
    Dubuquoy, L
    Jansson, EÅ
    Deeb, S
    Rakotobe, S
    Karoui, M
    Colombel, JF
    Auwerx, J
    Pettersson, S
    Desreumaux, P
    [J]. GASTROENTEROLOGY, 2003, 124 (05) : 1265 - 1276
  • [30] Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448